SCHEMBL28317349

SCHEMBL28317349

CC(=O)Cc1cc(-c2ccccc2Cl)ncn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 12/20 0.46
▸ CYP2C19 P33261 8/20 0.46
▸ CYP3A4 P08684 7/20 0.46
▸ CLK4 Q9HAZ1 7/20 0.46
▸ TSHR P16473 7/20 0.46
▸ CYP2D6 P10635 5/20 0.46
▸ MAPK1 P28482 4/20 0.46
▸ ALOX15 P16050 3/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ KMO O15229 1/20 0.43
▸ HIF1A Q16665 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ MAPK14 Q16539 1/20 0.41
▸ ALPL P05186 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ ABL1 P00519 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28876222 0.81 ALDH1A1 (0.41) CYP1A2CYP2C19CYP3A4CLK4TSHR
SCHEMBL26046037 0.79 KMO (0.54) CYP1A2CYP2C19CLK4CYP2D6ALDH1A1
SCHEMBL2414963 0.77 CYP1A2 (0.51) CYP1A2CYP2C19CYP3A4CLK4TSHR
SCHEMBL10939790 0.76 CYP1A2 (0.58) CYP1A2CYP2C19CYP3A4CLK4TSHR
SCHEMBL2411099 0.72 CYP1A2 (0.54) CYP1A2CYP2C19CYP3A4CLK4TSHR
SCHEMBL28318321 0.71 ADORA2B (0.43) MAPK1ALDH1A1TP53MAPTMEN1
SCHEMBL1445151 0.68 MIF (0.56) CYP1A2CYP2C19CYP3A4CLK4TSHR
SCHEMBL26046036 0.68 L3MBTL1 (0.35) CYP3A4MAPK1ALOX15ALDH1A1MAPT
SCHEMBL28479488 0.66 CYP1A2 (0.52) CYP1A2CYP2C19CYP3A4CLK4TSHR
SCHEMBL2413746 0.66 AVPR2 (0.41) CYP1A2CYP2C19CYP3A4CLK4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110214012-A Azole pyrimidines for the treatment of cancer-related diseases 艾库斯生物科学有限公司 2019-09-06 — — CN disclosed
Send feedback